Nothing Special   »   [go: up one dir, main page]

ATE229497T1 - Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren - Google Patents

Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren

Info

Publication number
ATE229497T1
ATE229497T1 AT97923621T AT97923621T ATE229497T1 AT E229497 T1 ATE229497 T1 AT E229497T1 AT 97923621 T AT97923621 T AT 97923621T AT 97923621 T AT97923621 T AT 97923621T AT E229497 T1 ATE229497 T1 AT E229497T1
Authority
AT
Austria
Prior art keywords
matrx
metalloprotease inhibitors
substituted phenethyl
phenethyl derivatives
derivatives
Prior art date
Application number
AT97923621T
Other languages
English (en)
Inventor
Donald J Wolanin
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of ATE229497T1 publication Critical patent/ATE229497T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/093Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/70Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/84Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups and doubly-bound oxygen atoms bound to the same carbon skeleton with the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/46Friedel-Crafts reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/76Unsaturated compounds containing keto groups
    • C07C59/88Unsaturated compounds containing keto groups containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/738Esters of keto-carboxylic acids or aldehydo-carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT97923621T 1996-05-15 1997-05-12 Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren ATE229497T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64502696A 1996-05-15 1996-05-15
PCT/US1997/007919 WO1997043247A1 (en) 1996-05-15 1997-05-12 Inhibition of matrix metalloproteases by substituted phenethyl compounds

Publications (1)

Publication Number Publication Date
ATE229497T1 true ATE229497T1 (de) 2002-12-15

Family

ID=24587359

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97923621T ATE229497T1 (de) 1996-05-15 1997-05-12 Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren

Country Status (24)

Country Link
EP (1) EP0907632B1 (de)
JP (1) JP3305328B2 (de)
CN (1) CN1124255C (de)
AR (1) AR007100A1 (de)
AT (1) ATE229497T1 (de)
AU (1) AU727899B2 (de)
BR (1) BR9709084A (de)
CA (1) CA2253870C (de)
CO (1) CO5070565A1 (de)
DE (1) DE69717811T2 (de)
DK (1) DK0907632T3 (de)
ES (1) ES2188943T3 (de)
HN (1) HN1997000071A (de)
HR (1) HRP970243B1 (de)
ID (1) ID17424A (de)
PA (1) PA8429801A1 (de)
PE (1) PE66298A1 (de)
PT (1) PT907632E (de)
SV (1) SV1997000037A (de)
TN (1) TNSN97082A1 (de)
TW (1) TW363056B (de)
WO (1) WO1997043247A1 (de)
YU (1) YU18497A (de)
ZA (1) ZA974029B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6288063B1 (en) * 1998-05-27 2001-09-11 Bayer Corporation Substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors
AU1982500A (en) 1998-12-30 2000-07-24 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
EP1031349A1 (de) * 1999-02-25 2000-08-30 Bayer Aktiengesellschaft Verwendung von substituierten 4-Biarylbuttersäuren und 5-Biarylpentansäuren zur Behandlung von zerebralen Krankheiten
US7141607B1 (en) 2000-03-10 2006-11-28 Insite Vision Incorporated Methods and compositions for treating and inhibiting retinal neovascularization
FR2901320B1 (fr) * 2006-05-17 2008-07-04 Univ Savoie Etablissement Publ Dispositif miniaturise apte a fonctionner comme moteur ou refroidisseur selon un cycle thermodynamique de stirling
CA2944617A1 (en) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft Chiral 2,5-disubstituted cyclopentanecarboxylic acid derivatives and use thereof
WO2015150363A1 (de) 2014-04-03 2015-10-08 Bayer Pharma Aktiengesellschaft 2,5-disubstituierte cyclopentancarbonsäuren und ihre verwendung
US20170114049A1 (en) 2014-04-03 2017-04-27 Bayer Pharma Aktiengesellschaft 2,5-disubstituted cyclopentane carboxylic acids for the treatment of respiratory tract diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
DE2112716A1 (de) * 1971-03-17 1972-10-05 Thomae Gmbh Dr K Neue 4-(4-Biphenylyl)-4-oxobuttersaeuren,ihre Salze und ihre Ester
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Also Published As

Publication number Publication date
DE69717811D1 (en) 2003-01-23
CO5070565A1 (es) 2001-08-28
EP0907632A1 (de) 1999-04-14
CN1124255C (zh) 2003-10-15
SV1997000037A (es) 1999-01-14
DE69717811T2 (de) 2003-05-28
ZA974029B (en) 1998-02-19
PA8429801A1 (es) 2000-05-24
HN1997000071A (es) 1997-06-18
CA2253870A1 (en) 1997-11-20
DK0907632T3 (da) 2003-04-07
CA2253870C (en) 2004-01-06
PT907632E (pt) 2003-04-30
AU2938597A (en) 1997-12-05
YU18497A (en) 1999-11-22
TW363056B (en) 1999-07-01
WO1997043247A1 (en) 1997-11-20
AR007100A1 (es) 1999-10-13
JP3305328B2 (ja) 2002-07-22
BR9709084A (pt) 1999-08-03
PE66298A1 (es) 1998-10-23
TNSN97082A1 (fr) 2005-03-15
HRP970243A2 (en) 1998-04-30
AU727899B2 (en) 2001-01-04
JPH11510517A (ja) 1999-09-14
CN1225624A (zh) 1999-08-11
HRP970243B1 (en) 2002-06-30
ID17424A (id) 1997-12-24
EP0907632B1 (de) 2002-12-11
ES2188943T3 (es) 2003-07-01

Similar Documents

Publication Publication Date Title
DE69725465D1 (de) 6-phenylpyridyl-2-amin-derivate verwendbar als nos-inhibitoren
ATE231132T1 (de) Heterocyclische metalloprotease inhibitoren
DE69824199D1 (de) Lactamverbindungen als metalloprotease-inhibitoren
ATE226573T1 (de) Heterozyklische metalloproteaseinhibitoren
DE69820906D1 (de) Hydroxamsäure-derivate als matrix metalloproteinaseinhibitoren
ATE244216T1 (de) Ketobenzamide als calpain-inhibitoren
ATE226590T1 (de) Phosphinsäureamide als matrix metalloprotease inhibitoren
ATE254106T1 (de) Cycloalkano-pyridine als cetp-inhibitoren
DK0927168T3 (da) 1,3-diheterocykliske metalloproteaseinhibitorer
NO20000464L (no) Acykliske metalloprotease-inhibitorer
DK1001934T3 (da) Indolforbindelser som COX-2-inhibitorer
ATE272062T1 (de) Spirocyclisch metalloprotease inhibitoren
DK0958287T3 (da) Sulfamidmetalloprotease-inhibitorer
FI973198A0 (fi) Silloitetut indolit matriisimetalloproteaasi-inhibiittoreina
ATE210112T1 (de) Substituierte 4-biphenyl-4- hydroxybuttersäurederivate als matrix metallprotease inhibitoren
ATE240317T1 (de) Indolderivate als pkc-inhibitoren
ATE229497T1 (de) Substituierte phenethyl-derivate als matrx- metalloprotease-inhibitoren
DE69707098D1 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
ATE205822T1 (de) Substituierte 4-arylbutyrsäurederivate als matrix metalloprotease inhibitoren
ATE221065T1 (de) Amidinderivate als inhibitoren von no-synthase
DE69418656D1 (de) 2-acyloxycephemderivate als elastaseinhibitoren
SE9703009D0 (sv) Anordning vid hydraulhammare

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0907632

Country of ref document: EP

REN Ceased due to non-payment of the annual fee